Back to "using a genetically encoded dopamine sen..."
Claim
Strong Support
descriptive
Analysis v3

When mice are given liraglutide, the usual dopamine spike caused by nicotine is reduced in the brain’s reward center.

6
Pro
0
Against

Evidence from Studies

Supporting (1)

6

Community contributions welcome

6

GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity

Cohort Study
Animal
2023 May 30

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Sign up to see full verdict

Source Study

GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity

Score: 6
DOI: 10.1016/j.celrep.2023.112466

Similar Assertions

When mice get both nicotine and liraglutide, several parts of their brain light up with activity, suggesting the two drugs work together in the brain.

6
0
79%